OptimizeRx Corporation
OPRX
$5.12
$0.224.49%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 13.76% | 18.78% | 24.18% | 25.90% | 20.66% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.76% | 18.78% | 24.18% | 25.90% | 20.66% |
| Cost of Revenue | -4.98% | 9.42% | 15.17% | 17.84% | 10.84% |
| Gross Profit | 24.23% | 23.94% | 29.57% | 30.84% | 26.95% |
| SG&A Expenses | -5.44% | -11.60% | -2.81% | -3.57% | 0.20% |
| Depreciation & Amortization | -1.38% | -0.07% | 2.36% | 20.56% | 44.91% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -4.76% | -0.76% | 7.00% | 8.12% | 8.97% |
| Operating Income | 578.24% | 302.11% | 192.25% | 138.59% | 72.75% |
| Income Before Tax | 159.56% | 135.91% | 105.09% | 64.61% | 36.33% |
| Income Tax Expenses | 497.83% | 152.28% | 118.17% | 106.92% | 90.42% |
| Earnings from Continuing Operations | 144.36% | 125.52% | 100.14% | 44.91% | 14.71% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 144.36% | 125.52% | 100.14% | 44.91% | 14.71% |
| EBIT | 578.24% | 302.11% | 192.25% | 138.59% | 72.75% |
| EBITDA | 1,285.10% | 1,102.55% | 420.62% | 226.25% | 116.64% |
| EPS Basic | 143.69% | 124.93% | 100.11% | 46.40% | 18.36% |
| Normalized Basic EPS | 217.02% | 161.18% | 115.12% | 88.36% | 34.41% |
| EPS Diluted | 140.86% | 123.08% | 99.69% | 46.28% | 18.67% |
| Normalized Diluted EPS | 212.54% | 157.98% | 114.40% | 88.03% | 34.41% |
| Average Basic Shares Outstanding | 1.41% | 1.43% | 2.00% | 4.07% | 5.60% |
| Average Diluted Shares Outstanding | 4.28% | 4.31% | 3.91% | 4.78% | 5.60% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |